DAEWOONG CO., LTD enters AEON BIOPHARMA, INC. with 12.01M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 1/29/2026ACC: 0001213900-26-009803
12.01M
Baseline shares
0% direct
58.02K
Direct ownership
1 position
19.24M
Derivative underlying
3 instruments
2
Security positions
11.95M indirect
Non-Derivative Holdings2
Common Stock, $0.0001 par value per share
IndirectShares owned11.95M
Common Stock, $0.0001 par value per share
DirectShares owned58.02K
Total
58.02K direct·11.95M indirect12.01M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.0001 par value per share | 11.95M | Indirect |
| Common Stock, $0.0001 par value per share | 58.02K | Direct |
| Total | 12.01M | 58.02K direct·11.95M indirect |
Derivative Holdings3
Senior Secured Convertible Note
IndirectUnderlying security
Common Stock
Underlying shares
N/A
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Common Stock Warrant
IndirectUnderlying security
Common Stock
Underlying shares
8M
Shares owned
N/A
Exercise price
1.0939
Expiration
—
Exercise window
—
Pre-Funded Warrants
IndirectUnderlying security
Common Stock
Underlying shares
11.24M
Shares owned
N/A
Exercise price
0.0001
Expiration
—
Exercise window
—
Total
Underlying
19.24M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Senior Secured Convertible Note Indirect | Common Stock | — | — | N/A | N/A | |
| Common Stock Warrant Indirect | Common Stock | 1.0939 | — | — | 8M | N/A |
| Pre-Funded Warrants Indirect | Common Stock | 0.0001 | — | — | 11.24M | N/A |
| Total | 19.24M | 0.00 | ||||